Steroid Drug ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
49	Systemic lupus erythematosus	1

46. Malignant rheumatoid arthritis

---

Clinical trials : 4,356 /  Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04344405 (ClinicalTrials.gov)	June 1, 2019	9/4/2020	Vitamin D as a Key Player in Rheumatoid Arthritis	Vitamin D as a Key Player in Rheumatoid Arthritis Immune Response	the Immunomodulatory Effect	Drug: Vitamin D;Drug: Steroid Drug	Assiut University	NULL	Completed	20 Years	70 Years	All	40	Phase 3	Egypt

49. Systemic lupus erythematosus

---

Clinical trials : 993 /  Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01753401 (ClinicalTrials.gov)	January 2013	17/12/2012	Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease	A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease	Systemic Lupus Erythematosus (SLE)	Drug: Acthar;Drug: Placebo;Drug: Steroid Drug	Mallinckrodt	NULL	Completed	18 Years	N/A	All	38	Phase 4	United States